Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Damora Therapeutics, Inc. (DMRA) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Damora Therapeutics, Inc. (DMRA) on November 11, 2026 is 24.41 $, +1.08 % on the day. Over 52 weeks the stock traded between 4.95 $ and 38.33 $; the price now sits 58 % of the way up that range. Over the past year the price changed by +386.26 %. Market capitalization is 1.48 billion $, rank 95 among 379 stocks of the same industry with a known capitalization.
Damora Therapeutics, Inc. trades on Nasdaq under the ticker DMRA. The company belongs to the Health care sector. The trading history on this page starts on 29 October 2020.
Over the past 52 weeks DMRA has traded between 4.95 $ and 38.33 $. As of 11 November 2026 the price stood 57.29% of the way from the 52-week low to the high.
Over one year DMRA shares rose 386.26%; over six months they fell 1.19%. Volatility over 90 days is 67.84%. Dividends are not included: this is price change only, as of 11 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 181, above the sector median of 3.7. Price to book is 2.9, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Damora Therapeutics, Inc. reported revenue of 8M $ and a net loss of 263M $ over the last four quarters. Net margin is −3,216.18%. Revenue changed by +1,540.96% year over year. Earnings per share are $7.70. Market capitalisation is 1.5B $.
DMRA has a return on equity of −50.93%, below the sector median of −40.58%. Return on assets is −48.35%, below the sector median of −30.08%. Operating margin is −3,312.00%, below the sector median of −20.96%.